| 发明名称 |
PHARMACEUTICAL COMPOSITION COMPRISING A SGLT2 INHIBITOR IN COMBINATION WITH A DPP-IV INHIBITOR. |
| 摘要 |
<p>The invention relates to a pharmaceutical composition according to claim 1 comprising a SGLT2 inhibitor in combination with a DPP IV inhibitor which is suitable in the treatment or prevention of one or more conditions selected from type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance and hyperglycemia. In addition the present invention relates to methods for preventing or treating of metabolic disorders and related conditions.</p> |
| 申请公布号 |
MX2010001560(A) |
申请公布日期 |
2010.03.11 |
| 申请号 |
MX20100001560 |
申请日期 |
2008.08.15 |
| 申请人 |
BOEHRINGER INGELHEIM INTERNATIONAL GMBH. |
发明人 |
MICHAEL MARK;FRANK HIMMELSBACH;KLAUS DUGI |
| 分类号 |
A61K45/06 |
主分类号 |
A61K45/06 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
